Table 1.
The correlations between clinical indicators and clusters in the TCGA database.
| Characteristic | Cluster 1 | Cluster 2 | P-value |
|---|---|---|---|
| Samples (n) | 243 | 187 | |
| Age, median (IQR) | 61 (56, 65) | 63 (57, 67) | 0.010 |
| Biochemical recurrence, n (%) | 0.018 | ||
| No | 219 (50.9%) | 153 (35.6%) | |
| Yes | 24 (5.6%) | 34 (7.9%) | |
| N stage, n (%) | <0.001 | ||
| N0 | 182 (48.5%) | 124 (33.1%) | |
| N1 | 23 (6.1%) | 46 (12.3%) | |
| Residual tumor, n (%) | 0.003 | ||
| No | 170 (40.6%) | 103 (24.6%) | |
| Yes | 68 (16.2%) | 78 (18.6%) | |
| Gleason score (GS), n (%) | <0.001 | ||
| GS = 6 | 30 (7%) | 9 (2.1%) | |
| GS = 7 | 149 (34.7%) | 57 (13.3%) | |
| GS = 8 | 29 (6.7%) | 30 (7%) | |
| GS = 9 | 35 (8.1%) | 91 (21.2%) | |
| T stage, n (%) | <0.001 | ||
| T2 | 111 (26.2%) | 44 (10.4%) | |
| T3 | 128 (30.2%) | 133 (31.4%) | |
| T4 | 0 (0%) | 8 (1.9%) |
IQR, interquartile range; GS, Gleason score.